Seminari de Recerca "Predictive tools for post stroke epilepsy"

  Sala d’actes de la planta baixa de l’Hospital General — See in map
22/11/2022 -- From 15:00h to 16:00h
Organize :
Institut de Recerca Vall d'Hebron (VHIR)
Modality: Semipresencial
Share it:

Dr. Laura Abraira del Fresno, Senior researcher, Research Group on Status Epilepticus and Acute Seizures (VHIR)

Stroke is the most frequent cause of epilepsy over 60 years. The present clinical risk factors are not enough to predict which patients are at greater risk of post- stroke epilepsy. Stroke related seizures can be triggered by acute metabolic disturbances secondary to brain damage (early-onset seizures) or appear spontaneously after a latent period of epileptogenesis (late-onset seizures or epilepsy). The epileptogenesis process involves multiple molecular changes that will make the brain tissue capable of generating spontaneous seizures. The role of these molecules after an acute stroke event has not been widely investigated. The study of clinical factors and blood biomarkers would let us deep into the mechanisms of the development of epilepsy and to identify some predictive biomarker. Thus, it will be helpful to investigate future modifying or preventive treatment strategies.

At the presentation we will talk about poststroke epilepsy, about the epileptogenesis process and we will describe the clinical factors and biomarkers present during acute stroke and analyze their association with stroke related seizures. A multimodal panel with both clinical variables and biomarkers would be helpful to identify the patients who are more likely to have either early-onset seizures or post-stroke epilepsy.

Host: Dr. Estevo Santamarina Pérez, Head of group Research Group on Status Epilepticus and Acute Seizures (VHIR)

Online connection:

Related activities

Jornada de Cáncer de cérvix localmente avanzado: Perspectivas en el manejo terapéutico

06/02/2023 - 09:00
Médicos especialistas y residentes de oncología radioterápica, oncología médica y ginecología, radiología y medicina nuclear, Enfermería, residentes especialistas de Física y Protección Radiológica .
More information

Curso de Aspectos claves para mejorar la vacunación en migrantes recién llegado

Edificio ICS Balmes C/ Gran Vía de les Corts Catalanes, 587, C/ de Balmes, 20. CP 08006, Barcelona
06/12/2023 - 16:00
Profesionales que trabajan con migrantes tanto en el ámbito sanitario como en lo social. Cómo: -Personas que trabajan en temas de Salud Pública tanto a nivel local como nacional -Personal que desarrolla sus funciones en centros de migrantes y centros de vacunación -Mediadores culturales -Trabajadores/as sociales -Personas que trabajan en áreas relacionadas con migración -Profesionales sanitarios (médicos; enfermeros/as; otros)
More information

V Jornada Infección y Terapias biológicas

06/12/2023 - 09:00
Médicos (facultativos y residentes) y Farmacéuticos que pautan terapias biológicas
More information

Challenges and barriers for gene therapies in rare neurological disorders: preparing the next generation of clinicians and researchers Hospital Universitari Vall d’Hebron, June 29th-30th Barcelona.

06/29/2023 - 13:00
More information

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.